Horrigan Jamie, Bhumi Sriya, Miller David, Jafri Mikram, Tadros Micheal
Department of Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH.
Department of Medicine, University of Connecticut Health Center, Farmington, CT.
J Clin Gastroenterol. 2023 Jan 1;57(1):39-47. doi: 10.1097/MCG.0000000000001801.
Opioid-induced constipation (OIC) is a common condition in older adults who may not be responsive to traditional laxative therapy. OIC is defined as new or worsening constipation symptoms that occur with initiation of or altering the dose of opioid analgesia. For adult patients with OIC and noncancer pain, we recommend considering nonpharmacologic interventions (eg, dietary measures, increased physical activity, and biofeedback training) and over-the-counter laxatives, followed by prescription opioid receptor antagonists (methylnaltrexone, naloxegol, and naldemedine) if traditional over-the-counter laxatives fail. Other options may include lubiprostone, linaclotide, plecanatide, and prucalopride; however, these are not indicated for OIC specifically or studied in older adults. Because of the complex nature of absorption, distribution, metabolism, and excretion in the aging population, all agents used to treat OIC must be evaluated individually and reevaluated as patients continue to age. This review will serve as a guide to managing OIC in older adults.
阿片类药物引起的便秘(OIC)在老年人中很常见,这些老年人可能对传统的泻药治疗没有反应。OIC被定义为在开始使用阿片类镇痛剂或改变其剂量时出现的新的或加重的便秘症状。对于患有OIC和非癌性疼痛的成年患者,我们建议考虑非药物干预措施(如饮食措施、增加体育活动和生物反馈训练)以及非处方泻药,如果传统的非处方泻药无效,则使用处方阿片受体拮抗剂(甲基纳曲酮、纳洛戈、纳地美定)。其他选择可能包括鲁比前列酮、利那洛肽、普卡那肽和普芦卡必利;然而,这些药物并非专门用于治疗OIC,也未在老年人中进行研究。由于老年人群吸收、分布、代谢和排泄的复杂性,所有用于治疗OIC的药物都必须单独评估,并随着患者年龄的增长进行重新评估。本综述将作为管理老年人OIC的指南。